Comparison between Icon Facilitators IPO and Sheel Biotech IPO.
Icon Facilitators IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Sheel Biotech IPO is a SME Bookbuilding proposed to list at NSE SME.
| Icon Facilitators IPO | Sheel Biotech IPO | |
|---|---|---|
| Logo |  | |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Khambatta Securities Ltd. | Narnolia Financial Services Ltd. |
| Registrar | Maashitla Securities Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Nikunj Stock Brokers Ltd. | Mansi Share & Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Icon Facilitators IPO is up to ₹18.15 Cr whereas the issue size of the Sheel Biotech IPO is up to ₹32.31 Cr. The final issue price of Icon Facilitators IPO is ₹91.00 per share and of Sheel Biotech IPO is ₹63.00 per share.
| Icon Facilitators IPO | Sheel Biotech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹85.00 per share | ₹59.00 per share |
| Issue Price (Upper) | ₹91.00 per share | ₹63.00 per share |
| Issue Price (Final) | ₹91.00 per share | ₹63.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 2000 shares |
| Fresh Issue Size | 19,94,400 shares | 51,28,000 shares |
| Fresh Issue Size (Amount) | up to ₹18.15 Cr | up to ₹32.31 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 19,94,400 shares | 51,28,000 shares |
| Issue Size Total (Amount) | up to ₹18.15 Cr | up to ₹32.31 Cr |
Icon Facilitators IPO opens on Jun 24, 2025, while Sheel Biotech IPO opens on Sep 30, 2025. The closing date of Icon Facilitators IPO and Sheel Biotech IPO is Jun 26, 2025, and Oct 03, 2025, respectively.
| Icon Facilitators IPO | Sheel Biotech IPO | |
|---|---|---|
| Anchor Bid Date | Sep 29, 2025 | |
| Issue Open | Jun 24, 2025 | Sep 30, 2025 |
| Issue Close | Jun 26, 2025 | Oct 03, 2025 |
| Basis Of Allotment (Tentative) | Jun 27, 2025 | Oct 06, 2025 |
| Initiation of Refunds (Tentative) | Jun 30, 2025 | Oct 07, 2025 |
| Credit of Share (Tentative) | Jun 30, 2025 | Oct 07, 2025 |
| Listing date (Tentative) | Jul 01, 2025 | Oct 08, 2025 |
| Anchor Lockin End date 1 | Nov 05, 2025 | |
| Anchor Lockin End date 2 | Jan 04, 2026 |
Icon Facilitators IPO P/E ratio is 11.72, as compared to Sheel Biotech IPO P/E ratio of 8.86.
| Icon Facilitators IPO | Sheel Biotech IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Icon Facilitators Ltd.'s revenue increased by 16% and profit after tax (PAT) rose by 154% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Sheel Biotech Ltd.'s revenue increased by 11% and profit after tax (PAT) rose by 2% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 95.65 | 96.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 70.09 | 71.26 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 11.72 | 8.86 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹71.52 Cr. | ₹128.22 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 35.23 | 13.59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 37.09 | 16.34 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.35 | 0.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹7.76 | ₹7.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 35.23 | 13.59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Icon Facilitators IPO Retail Individual Investors (RII) are offered 9,46,800 shares while in Sheel Biotech IPO retail investors are offered 9,46,800 shares. Qualified Institutional Buyers (QIB) are offered in Icon Facilitators IPO and 10,26,000 shares in Sheel Biotech IPO.
| Icon Facilitators IPO | Sheel Biotech IPO | |
|---|---|---|
| Anchor Investor Reservation | 15,24,000 shares | |
| Market Maker Reservation | 1,05,600 shares | 2,72,000 shares |
| QIB | 10,26,000 shares | |
| NII | 9,46,800 shares | 7,74,000 shares |
| RII | 9,46,800 shares | 18,04,000 shares |
| Employee | 0 shares | |
| Others | ||
| Total | 19,94,400 shares | 51,28,000 shares |
Icon Facilitators IPO subscribed 2.49x in total, whereas Sheel Biotech IPO subscribed 15.97x.
| Icon Facilitators IPO | Sheel Biotech IPO | |
|---|---|---|
| QIB (times) | 2.18x | 19.73x |
| NII (times) | 0.92x | 25.92x |
| Big NII (times) | 31.64x | |
| Small NII (times) | 14.49x | |
| RII (times) | 4.10x | 9.56x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.49x | 15.97x |
